Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Solid TumorBrain TumorLymphoma
Interventions
OTHER

Blood samples obtained

Research participants agree to have blood samples obtained at the time of diagnosis before any chemotherapy, if available, and prior to high dose chemotherapy regimen with autologous HSCT as well as on days 14, 21, 28, week 8 and months 3, 6, 12 and 18 after autologous HSCT. Research participants with high risk neuroblastoma may also agree to have blood samples taken before and twice in the recovery period (days 0, 7 and 15-18) of Induction chemotherapy courses one and four.

Trial Locations (1)

38103

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT01540175 - Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant | Biotech Hunter | Biotech Hunter